"There should be a balance between export controls for national security as well as ensuring that we get the widest possible adoption," she said. ​Read More
Chip companies from AMD to Super Micro said U.S. tariff policy and export restrictions to China have caused uncertainty for their businesses. ​Read More
A week after issuing disappointing preliminary results, Super Micro said in its earnings release that it could see an impact from President Trump's tariffs. ​Read More
AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy manufacturing facility in Maryland to help treat cancer patients. The U.K-based pharmaceutical giant said the new $300 million facility in Rockville symbolizes its confidence in America’s role as a “global leader in science, manufacturing and economic growth.”
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.